Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement.

Farheen, Jabeen; Hosmane, Narayan S; Zhao, Ruibo; Zhao, Qingwei; Iqbal, M Zubair; Kong, Xiangdong

Farheen, Jabeen; Hosmane, Narayan S; Zhao, Ruibo; Zhao, Qingwei; Iqbal, M Zubair; Kong, Xiangdong.

Afiliación

Farheen J; Institute of Smart Biomedical Materials, School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, PR China.
Hosmane NS; Zhejiang-Mauritius Joint Research Centre for Biomaterials and Tissue Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, PR China.
Zhao R; Department of Chemistry & Biochemistry, Northern Illinois University, DeKalb, IL, 60115, USA.
Zhao Q; Institute of Smart Biomedical Materials, School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, PR China.
Iqbal MZ; Zhejiang-Mauritius Joint Research Centre for Biomaterials and Tissue Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, PR China.
Kong X; Department of Materials, Imperial College London, London, SW7 2AZ, UK.

Mater Today Bio ; 16: 100450, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36267139

Palabras clave

CRISPR/Cas9; Gene therapy; Genetic mechanism; Nanocarriers; Triple-negative breast cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mater Today Bio Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google